Derivation Web

v0.1 · api

Chain for claim_690e035aac83466b

8 nodes. Root first; inputs below.

depth 0 · claim · via classify
claim_690e035aac83466b
# Adjacent Evidence Brief: Everolimus — full paper

## Abstract

Evidence-honesty note: 24/27 retained sources are coded as null or no extracted directional signal; this corpus is non-supportive for clinical efficacy claims and hypothesis-generating only. Source-bundle reconciliation note: Directional coding is conservative claim-level coding from extracted claim records, not a statement that the …
sha256 aa52edc3f17bd5aa…
depth 1 · source
source_2e522cfe7a574745
# Adjacent Evidence Brief: Everolimus — full paper

## Abstract

Evidence-honesty note: 24/27 retained sources are coded as null or no extracted directional signal; this corpus is non-supportive for clinical efficacy claims and hypothesis-generating only. Source-bundle reconciliation note: Directional coding is conservative claim-level coding from extracted claim records, not a statement that the …
sha256 6d0f42856109c5e6…
depth 1 · source
source_29c9d84060bb4776
{"publication_id": "3f0afbf6-e835-4b75-ae70-8dfca79bcb14", "traces": [{"candidate_sources": [{"doi": "10.1186/s40360-025-01079-8", "study": "Impact of aging on the pharmacokinetic profile of everolimus in male mice", "url": "https://doi.org/10.1186/s40360-025-01079-8"}, {"doi": "10.3389/fimmu.2021.753412", "study": "Everolimus Alleviates Renal Allograft Interstitial Fibrosis by Inhibiting Epitheli…
sha256 ba0e26c59f921ab9…
depth 1 · source
source_a87687c4f2db4ca7
{"content_hash": "sha256:7b872ec29d67243481f23d4db57722ef060a95ad2797fcba9e738f227a02fd34", "edges": [{"from": "3f0afbf6-e835-4b75-ae70-8dfca79bcb14", "to": "claim_1", "type": "contains_claim"}, {"from": "3f0afbf6-e835-4b75-ae70-8dfca79bcb14", "to": "claim_2", "type": "contains_claim"}, {"from": "3f0afbf6-e835-4b75-ae70-8dfca79bcb14", "to": "claim_3", "type": "contains_claim"}, {"from": "3f0afbf6-…
sha256 858ea495719076e5…
depth 1 · source
source_5d3bc66cf0d24acc
{"contradictions": ["The conclusion is that Everolimus remains a bounded geroscience case: the retained clinical and adjacent evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.", "Source-context verification gap: 5 source-bundle records have no DOI, PMID, PMCID, or trial identifier in the available metadata. They remain tr…
sha256 3e3a7225d109e415…
depth 1 · source
source_f12a4e51b76e4e47
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
Impact of aging on the pharmacokinetic profile of everolimus in male mice,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Everolimus Alleviates Renal Allograft Interstitial Fibrosis by Inhibiting Epithelial-to-Mesenchymal Transition Not Only v…
sha256 ec35d22a3962c941…
depth 1 · source
source_a478ff3c82ea44ac
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "3f0afbf6-e835-4b75-ae70-8dfca79bcb14", "sources": [{"directness": "primary", "doi": "10.1186/s40360-025-01079-8", "risk_of_bias": "not appraised in public sidecar", "study": "Impact of aging on the pharmacokinetic profile of everolimus i…
sha256 fd7b50e2f9bfa6ef…
depth 1 · source
source_dd7d1905c10f4ad6
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 ee15ff52b87c31f6…